Keywords: Neuroendocrine carcinoma drugs, Market forecasts, GlobalData, Pipeline candidates

Neuroendocrine carcinoma therapeutics to see strong growth to 2017

Article | 27 October 2011

The global neuroendocrine carcinoma therapeutics market was worth $91 million in 2010, and is forecast to grow at Compound Annual Growth Rate ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in